NCT07518043 2026-04-15
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
Shanghai Henlius Biotech
Assiut University
CSPC Megalith Biopharmaceutical Co.,Ltd.
Gruppo Oncologico Italiano di Ricerca Clinica
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Istituto Clinico Humanitas
Pfizer